{"id":50561,"date":"2012-08-02T21:14:24","date_gmt":"2012-08-02T21:14:24","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/vet-medicine-supplier-fined.php"},"modified":"2012-08-02T21:14:24","modified_gmt":"2012-08-02T21:14:24","slug":"vet-medicine-supplier-fined","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/vet-medicine-supplier-fined.php","title":{"rendered":"Vet medicine supplier fined"},"content":{"rendered":"<p><p>A VETERINARY medicine supplier, Ceva Animal Health (formerly  Nature Vet), was convicted last week on two counts under  Australias agvet chemical laws for supplying veterinary  antibiotics contrary to their permit conditions.  <\/p>\n<p>    Under permit, Ceva was allowed to sell a combination of two    antibioticsrifampicin and erythromycinunder very strict    conditions to minimise the risk of antibiotic resistance    developing. Both these antibiotics are important in human as    well as animal medicine, with rifampicin being regarded as    high importance in treating bacterial infections that are    resistant to other antibiotics.  <\/p>\n<p>    The APVMA uncovered the permit breaches through a compliance    audit, following some irregularities identified through routine    internal screening, said APVMAs Compliance Manager, Dr Jan    Klaver.  <\/p>\n<p>    Following Cevas guilty plea in the NSW Local Court, the court    found the offences proven.  <\/p>\n<p>    Ceva was convicted and fined $5000 for supplying the    antibiotics contrary to requirements of Section 78 (1) of the    Agricultural and Veterinary Chemicals Code Act 1994.  <\/p>\n<p>    The company was also convicted and fined a further $3000 for    wrongfully supplying these antibiotics beyond their use-by    date. Costs were also awarded to the APVMA.  <\/p>\n<p>    The APVMA is actively monitoring compliance of agvet chemicals    and their supply with relevant manufacturing, registration and    permit conditions, Dr Klaver said.  <\/p>\n<p>    We make no apologies for taking strong action against    companies who take chances with these products and even more so    when we are dealing with products that are so important to    human medicine as well.  <\/p>\n<p>    The combination of erythromycin and rifampicin is a treatment    of choice for Rhodococcus equi infectionan important cause of    pneumonia in foalswhich may become established as an endemic    disease at breeding facilities.  <\/p>\n<p>    Immuno-compromised people, such as transplant patients or those    with HIV-AIDS may also be at risk of contracting R. equi    infections.  <\/p>\n<\/p>\n<p>Go here to see the original:<\/p>\n<p><a target=\"_blank\" href=\"http:\/\/nqr.farmonline.com.au\/news\/nationalrural\/agribusiness-and-general\/general\/vet-medicine-supplier-fined\/2616972.aspx?src=rss\" title=\"Vet medicine supplier fined\">Vet medicine supplier fined<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> A VETERINARY medicine supplier, Ceva Animal Health (formerly Nature Vet), was convicted last week on two counts under Australias agvet chemical laws for supplying veterinary antibiotics contrary to their permit conditions. Under permit, Ceva was allowed to sell a combination of two antibioticsrifampicin and erythromycinunder very strict conditions to minimise the risk of antibiotic resistance developing. Both these antibiotics are important in human as well as animal medicine, with rifampicin being regarded as high importance in treating bacterial infections that are resistant to other antibiotics.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/medicine\/vet-medicine-supplier-fined.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[35],"tags":[],"class_list":["post-50561","post","type-post","status-publish","format-standard","hentry","category-medicine"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50561"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=50561"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/50561\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=50561"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=50561"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=50561"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}